Clinical overview
Identify source and resistance risk, achieve source control and use susceptibility-guided treatment with appropriate duration.
Why this matters
This topic can materially affect diagnosis, treatment safety, organ function and long-term outcome. Interpretation should integrate severity, trajectory, comorbidity, medicines and the patient’s goals rather than relying on one result or score.
Initial assessment
Define syndrome, illness severity, immune status, recent healthcare exposure, travel, devices, antimicrobial history and likely anatomical source. Obtain appropriate microbiology before treatment when this does not create unsafe delay.
Diagnostic strategy
Use cultures, molecular tests, imaging and source sampling selectively. Interpret colonisation, contamination and resistance in clinical context and repeat sampling when persistent infection or treatment failure is suspected.
Management principles
Begin timely empirical treatment for severe infection, achieve source control, optimise dose and route and review at 48 to 72 hours for de-escalation, oral switch, duration and an alternative diagnosis.
Monitoring and treatment safety
Define baseline measurements, treatment targets, adverse-effect surveillance and the interval for review. Reassess diagnosis, adherence, interactions, organ function and treatment burden when the expected response is not achieved.
Special populations
Pregnancy, childhood, older age, frailty, kidney or liver dysfunction and immunosuppression may change diagnostic performance, medicine selection, dose and escalation thresholds. Use population-specific guidance and specialist advice.
Clinical pearls
- Trend and clinical trajectory are often more informative than a single measurement.
- Obtain definitive tissue, microbiology or fluid evidence when it will alter management.
- Document why a score, threshold or guideline applies to this patient.
Common mistakes
- Using screening or classification criteria as a stand-alone diagnosis.
- Failing to review medicines, interactions and organ function.
- Continuing ineffective treatment without reassessing the diagnosis or source.
- Delaying supportive, rehabilitative or palliative care until late in the pathway.
Escalation triggers
Escalate urgently for sepsis, meningitis, encephalitis, severe immunosuppression, necrotising infection, persistent bacteraemia, uncontrolled source or multidrug resistance, or whenever ward-level monitoring, diagnostic access or treatment capability is insufficient.
Related MediCalc clinical tools
Related Clinical References
Frequently asked questions
Can this reference replace a local specialist pathway?
No. Use current local prescribing, diagnostic, antimicrobial, transfusion, rheumatology or oncology protocols as applicable.
When should the diagnosis be reconsidered?
Reconsider it when the clinical course, repeat testing or treatment response is inconsistent with the working diagnosis.
Key practice points
- Recognise emergencies first.
- Obtain high-quality diagnostic evidence.
- Use specialist treatment safely.
- Reassess response and toxicity.
- Integrate prevention, rehabilitation and supportive care.